Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial. - Concepedia

Concepedia

Publication | Closed Access

Konjac-mannan (glucomannan) improves glycemia and other associated risk factors for coronary heart disease in type 2 diabetes. A randomized controlled metabolic trial.

249

Citations

0

References

1999

Year

Vladimir Vuksan, David Jenkins, P Spadafora, John L. Sievenpiper, R Owen, E. Vidgen, Furio Brighenti, Robert G. Josse, Lawrence A. Leiter, Charles Bruce-Thompson

Abstract

KJM fiber added to conventional treatment may ameliorate glycemic control, blood lipid profile, and sBP in high-risk diabetic individuals, possibly improving the effectiveness of conventional treatment in type 2 diabetes.